Cancer Epidemiology
Volume 34, Issue 1 , Pages 24-28 , February 2010

The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997–2001: A survey of patients aged ≥65 years

  • Katrin Palk

      Affiliations

    • Department of Hematology, North Estonian Regional Hospital, Tallinn, Estonia
    • ,
  • Ene Luik

      Affiliations

    • Clinic of Hematology and Oncology, Tartu University Clinics, Tartu, Estonia
    • ,
  • Mirja Varik

      Affiliations

    • Department of Hematology, North Estonian Regional Hospital, Tallinn, Estonia
    • ,
  • Iige Viigimaa

      Affiliations

    • Department of Hematology, North Estonian Regional Hospital, Tallinn, Estonia
    • ,
  • Krista Vaht

      Affiliations

    • Department of Hematology, North Estonian Regional Hospital, Tallinn, Estonia
    • Hematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, 413 45 Göteborg, Sweden
    • ,
  • Hele Everaus

      Affiliations

    • Clinic of Hematology and Oncology, Tartu University Clinics, Tartu, Estonia
    • ,
  • Lovisa Wennström

      Affiliations

    • Hematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, 413 45 Göteborg, Sweden
    • ,
  • Dick Stockelberg

      Affiliations

    • Hematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, 413 45 Göteborg, Sweden
    • ,
  • Soodabeh Safai-Kutti

      Affiliations

    • Hematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, 413 45 Göteborg, Sweden
    • ,
  • Erik Holmberg

      Affiliations

    • Oncological Centre, Sahlgrenska University Hospital, Göteborg, Sweden
    • ,
  • Jack Kutti

      Affiliations

    • Hematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, 413 45 Göteborg, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 31 3423454; fax: +46 31 416488.

,Accepted 9 December 2009.

References 

  1. Luik E, Palk K, Everaus H, Varik M, Aareleid T, Wennström L, et al. The incidence and survival of acute de novo leukaemias in Estonia and in a well-defined region of western Sweden during 1982–1996: a survey of patients aged ≥65 years. J Intern Med. 2004;256:79–85
  2. Wennström L, Juntikka E-L, Safai-Kutti S, Stockelberg D, Holmberg E, Luik E, et al. The incidence and survival of acute de novo leukaemias in Estonia and in a well defined region of western Sweden during 1982–1996: a survey of patients aged 16–64 years. Leuk Lymphoma. 2004;45:915–921
  3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620–625
  4. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8:813–819
  5. Öst Å, Reizenstein P. Minimal diagnostic criteria for the myelodysplastic syndrome. Leuk Res. 1992;16:9–11
  6. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of myeloid neoplasms. Blood. 2002;100:2292–2302
  7. Juliusson G, Billström R, Gruber A, Hellstöm-Lindberg E, Höglund M, Karlsson K, et al. Attitude towards remission induction for elderly patients with acute myeloid leukaemia influences survival. Leukemia. 2006;20:42–47
  8. Rothmann KJ. Modern epidemiology. Boston: Little, Brown and Company; 1986;
  9. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23:51–64
  10. StataCorp . Stata Statistical Software: Release 10. College Station, TX: StataCorp LP; 2007;
  11. Taylor PRA, Reid MM, Proctor SJ. Acute lymphoblastic leukaemia in the elderly. Leuk Lymphoma. 1994;13:373–380
  12. Taylor PRA, Reid MM, Stark AN, Bown N, Hamilton PJ, Proctor SJ. De novo acute myeloid leukaemia in patients over 55-years-old: a population-based study of incidence, treatment and outcome. Leukemia. 1995;9:231–237
  13. Taylor PRA, Reid MM, Bown N, Hamilton PJ, Proctor SJ. Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome. Blood. 1992;80:1813–1817
  14. Pulte D, Gondos A, Brenner H. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Hematologica. 2008;93:594–600

PII: S1877-7821(09)00183-0

doi: 10.1016/j.canep.2009.12.004

Cancer Epidemiology
Volume 34, Issue 1 , Pages 24-28 , February 2010

Article Tools